Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 4/20 | 0.31 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5774833 | 0.86 | GPR119 (0.36) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5777356 | 0.78 | AAK1 (0.35) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5776578 | 0.75 | IMPDH2 (0.35) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5779359 | 0.65 | IMPDH2 (0.35) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5779356 | 0.65 | IMPDH2 (0.35) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5912671 | 0.64 | IMPDH2 (0.34) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5774837 | 0.63 | IMPDH2 (0.39) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5779104 | 0.63 | AAK1 (0.38) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5779456 | 0.58 | GPR119 (0.45) | AAK1IMPDH2IMPDH1 | |
| SCHEMBL5779035 | 0.58 | IMPDH2 (0.60) | AAK1IMPDH2IMPDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1612204-A1 | HYDRAZONE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | APP, PRNP, HTT | ATR 2387/4885AAK1 1161/4885IMPDH2 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.